LU90939I2 - 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates - Google Patents

3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates

Info

Publication number
LU90939I2
LU90939I2 LU90939C LU90939C LU90939I2 LU 90939 I2 LU90939 I2 LU 90939I2 LU 90939 C LU90939 C LU 90939C LU 90939 C LU90939 C LU 90939C LU 90939 I2 LU90939 I2 LU 90939I2
Authority
LU
Luxembourg
Prior art keywords
tetrahhydrocarbazole
methtylamino
frovatriptan
solvate
hydrate salts
Prior art date
Application number
LU90939C
Other languages
English (en)
French (fr)
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90939(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Publication of LU90939I2 publication Critical patent/LU90939I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU90939C 1991-06-26 2002-07-24 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates LU90939I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments
PCT/GB1992/001082 WO1993000086A1 (en) 1991-06-26 1992-06-17 Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists

Publications (1)

Publication Number Publication Date
LU90939I2 true LU90939I2 (fr) 2002-09-24

Family

ID=10697363

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90939C LU90939I2 (fr) 1991-06-26 2002-07-24 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates

Country Status (34)

Country Link
US (2) US5464864A (https=)
EP (1) EP0591280B1 (https=)
JP (1) JP3261502B2 (https=)
KR (1) KR100251571B1 (https=)
CN (1) CN1034072C (https=)
AP (1) AP344A (https=)
AT (1) ATE170746T1 (https=)
BR (2) BR9206237A (https=)
CA (1) CA2113726C (https=)
CZ (3) CZ282327B6 (https=)
DE (2) DE69226953T2 (https=)
DK (1) DK0591280T3 (https=)
FI (1) FI103967B1 (https=)
GB (1) GB9113802D0 (https=)
HU (1) HU218907B (https=)
IE (1) IE922062A1 (https=)
IL (4) IL117105A (https=)
LU (1) LU90939I2 (https=)
MA (1) MA22563A1 (https=)
MX (1) MX9203444A (https=)
NL (1) NL300103I2 (https=)
NO (2) NO304774B1 (https=)
NZ (1) NZ243288A (https=)
PL (3) PL169392B1 (https=)
PT (1) PT100620B (https=)
RU (1) RU2137474C1 (https=)
SA (1) SA92130141B1 (https=)
SG (1) SG47877A1 (https=)
SI (1) SI9200125B (https=)
SK (3) SK280906B6 (https=)
TW (1) TW214544B (https=)
UA (1) UA41254C2 (https=)
WO (1) WO1993000086A1 (https=)
ZA (1) ZA924658B (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
EP0749962B1 (en) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
WO2003029214A1 (en) * 2001-09-28 2003-04-10 F. Hoffmann-La Roche Ag Pseudopolymorphic forms of carvedilol
BR0312176A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmaceutica, uso de um composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso, processo para a preparação de um composto, novo intermediario e processo para a preparação de um novo intermediario
AU2003249584B9 (en) 2002-06-21 2008-05-15 Suven Life Sciences Limited Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
BRPI0315959C1 (pt) 2002-11-28 2021-05-25 Suven Life Sciences Ltd composto, composição farmacêutica, uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto
PT1567492E (pt) 2002-11-28 2013-07-22 Suven Life Sciences Ltd N-arilsulfonil-3-aminoalcoxi-indóis
DK1581538T3 (da) 2002-12-18 2007-06-25 Suven Life Sciences Ltd Tetracykliske 3-substituerede indoler med serotoninreceptoraffinitet
RU2430088C2 (ru) * 2004-07-14 2011-09-27 Центарис Гмбх Производные тетрагидрокарбазола и фармацевтическая композиция на их основе
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
BRPI0715179A2 (pt) * 2006-08-07 2013-06-11 Actelion Pharmaceuticals Ltd composto, composiÇço farmacÊutica e uso de um composto
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
ES2620672T3 (es) 2008-01-09 2017-06-29 Charleston Laboratories, Inc. Comprimidos de doble capa que comprenden oxicodona y prometazina
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
WO2011050140A1 (en) 2009-10-22 2011-04-28 Blue Fury Consulting, L.L.C. Posterior cervical fusion system and techniques
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
EP3628325A1 (en) 2011-07-22 2020-04-01 The University of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions
EP2816030A1 (en) 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan
AU2024326262A1 (en) * 2023-08-13 2026-03-26 GATC Health Corp Compounds and methods for treating addiction
CN119499195A (zh) * 2024-11-26 2025-02-25 青岛国信制药有限公司 一种快速吸收琥珀酸呋罗曲坦片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US3959309A (en) 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (de) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Tetrahydrocarbazolderivate

Also Published As

Publication number Publication date
CZ282061B6 (cs) 1997-05-14
FI935842A7 (fi) 1993-12-23
IL117104A0 (en) 1996-06-18
IL117105A (en) 1998-01-04
SK131993A3 (en) 1994-06-08
US5637611A (en) 1997-06-10
MA22563A1 (fr) 1992-12-31
IE922062A1 (en) 1992-12-30
US5464864A (en) 1995-11-07
GB9113802D0 (en) 1991-08-14
DE10299042I1 (de) 2003-02-20
IL102322A (en) 1997-09-30
ATE170746T1 (de) 1998-09-15
SI9200125B (en) 2001-12-31
FI103967B (fi) 1999-10-29
PT100620A (pt) 1993-09-30
AU652842B2 (en) 1994-09-08
IL102322A0 (en) 1993-01-14
BR1100460A (pt) 2000-07-18
TW214544B (https=) 1993-10-11
DE69226953T2 (de) 1999-05-12
NL300103I2 (nl) 2003-02-03
WO1993000086A1 (en) 1993-01-07
HU218907B (hu) 2000-12-28
PL169392B1 (pl) 1996-07-31
EP0591280B1 (en) 1998-09-09
AP344A (en) 1994-07-05
CZ282083B6 (cs) 1997-05-14
UA41254C2 (uk) 2001-09-17
SA92130141B1 (ar) 2005-12-18
FI103967B1 (fi) 1999-10-29
NO304774B1 (no) 1999-02-15
NO934800L (no) 1993-12-23
AU1977592A (en) 1993-01-25
CA2113726C (en) 2008-02-19
NZ243288A (en) 1994-09-27
PL171034B1 (en) 1997-02-28
CZ150696A3 (en) 1997-06-11
JP3261502B2 (ja) 2002-03-04
DK0591280T3 (da) 1999-02-15
PT100620B (pt) 1999-01-29
IL117104A (en) 1997-09-30
SG47877A1 (en) 1998-04-17
ZA924658B (en) 1993-12-24
SI9200125A (en) 1992-12-31
SK280906B6 (sk) 2000-09-12
DE10299042I2 (de) 2005-02-03
HK1014669A1 (en) 1999-09-30
JPH06508827A (ja) 1994-10-06
KR100251571B1 (ko) 2000-07-01
PL169410B1 (pl) 1996-07-31
BR9206237A (pt) 1995-04-11
NL300103I1 (nl) 2002-12-02
HUT68961A (en) 1995-08-28
CZ282327B6 (cs) 1997-06-11
NO934800D0 (no) 1993-12-23
DE69226953D1 (de) 1998-10-15
FI935842A0 (fi) 1993-12-23
SK280907B6 (sk) 2000-09-12
AP9200403A0 (en) 1992-07-31
CZ150596A3 (en) 1997-05-14
NO2005011I1 (no) 2005-05-18
CZ286193A3 (en) 1994-07-13
CN1034072C (zh) 1997-02-19
RU2137474C1 (ru) 1999-09-20
NO2005011I2 (no) 2008-02-11
CA2113726A1 (en) 1993-01-07
CN1069726A (zh) 1993-03-10
MX9203444A (es) 1993-12-01
IL117105A0 (en) 1996-06-18
EP0591280A1 (en) 1994-04-13
SK280905B6 (sk) 2000-09-12

Similar Documents

Publication Publication Date Title
LU90939I2 (fr) 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates
GB2256295B (en) Data storage and apparatus
ZA929700B (en) Piperidinyl and pieraziny alkyl indolones.
EP0438961A3 (en) Hardware data string operation controller
EP0457563A3 (en) Slant rig cementing apparatus
DE69212210D1 (de) Sicherheitstrokar
GB9018928D0 (en) Laptop computer
EP0548928A3 (en) Portable computer
EP0465894A3 (en) Drilling device
SG43849A1 (en) Memory mapped keyboard controller
EP0520707A3 (en) Data storage apparatus
GB9111730D0 (en) Portable drilling apparatus
NO921851L (no) "navlestreng"-frigjoeringsmekanisme
GB9101207D0 (en) Data security device
GB9209442D0 (en) Drilling device
EP0517162A3 (en) Boring and mortising device
AU115858S (en) Portable Computer
GB9127506D0 (en) Security of stored data
AU115857S (en) Portable Computer
EP0533373A3 (en) Computer system having cache memory
GB9113751D0 (en) Computer security
GB9218156D0 (en) Improved drilling apparatus
GB2262443B (en) Wall marking device
ZA916920B (en) Bit stuffing apparatus
CS434890A3 (en) Drilling device